At a Glance
| Psilocin | 1cP-AL-LAD | |
|---|---|---|
| Class | Psychedelic | Psychedelic |
| Common Dose (oral) | 8–15 mg | 100–225 µg |
| Total Duration | 75–120 min | 3.3–7 hrs |
| Routes | Oral | oral |
| Effects | 29 documented | 72 documented |
Psilocin, a Psychedelic, and 1cP-AL-LAD, a Psychedelic, are frequently compared by users looking to understand their relative effects, dosage profiles, and safety considerations. Both are classified as Psychedelics, meaning they share a common pharmacological foundation. They share 21 documented effects in common, with 8 effects unique to Psilocin and 51 unique to 1cP-AL-LAD. This side-by-side comparison covers dosage, duration, subjective effects, and safety to help you make informed decisions.
| Psilocin | 1cP-AL-LAD | |
|---|---|---|
| Class | Psychedelic | Psychedelic |
| Common Dose (oral) | 8–15 mg | 100–225 µg |
| Total Duration | 75–120 min | 3.3–7 hrs |
| Routes | Oral | oral |
| Effects | 29 documented | 72 documented |
| Level | Psilocin | 1cP-AL-LAD |
|---|---|---|
| Threshold | 3 mg | 20 µg |
| Light | 5–8 mg | 50–100 µg |
| Common | 8–15 mg | 100–225 µg |
| Strong | 15–25 mg | 225–350 µg |
| Heavy | 25 mg | 350 µg |
Psilocin
1cP-AL-LAD
No direct interaction data available between these substances. This does not mean the combination is safe.
No dangerous interactions recorded.
No dangerous interactions recorded.